Model predicts death due to acetaminophen overdose

Model predicts death due to acetaminophen overdose
Model for Acetaminophen-induced Liver Damage, a mathematical model that utilizes commonly obtained laboratory values, including overdose amount and time elapsed since overdose, is effective for predicting outcomes in patients with acute liver failure due to acetaminophen overdose, according to research published online Feb. 13 in Hepatology.

(HealthDay) -- Model for Acetaminophen-induced Liver Damage (MALD), a mathematical model that utilizes commonly obtained laboratory values, including overdose amount and time elapsed since overdose, is effective for predicting outcomes in patients with acute liver failure due to acetaminophen overdose, according to research published online Feb. 13 in Hepatology.

Christopher H. Remien, of the University of Utah in Salt Lake City, and colleagues developed MALD to describe acute due to an overdose of acetaminophen. The model utilizes laboratory values that are commonly obtained on admission, specifically aspartate aminotransferase (AST), alanine aminotransferase (ALT), and international normalized ratio (INR), to estimate the overdose amount, time elapsed, and outcome. The model was tested on 53 patients.

The researchers found that, using only initial ALT, AST, and INR measurements, the model was able to accurately predict follow-up laboratory values for most patients. With the addition of , the researchers were able to predict eventual death due to acetaminophen overdose with 100 percent sensitivity, 91 percent specificity, 67 percent , and 100 percent negative predictive value.

"Our dynamic model yields a prediction of outcome by estimating the time since overdose and overdose amount from commonly obtained laboratory data on admission," the authors write. "Our initial analysis suggests that MALD compares favorably to statistical methods, and should be validated in multicentric retrospective and prospective evaluation."

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Better labeling could help thwart acetaminophen overdose

May 03, 2011

While well known for relieving everyday aches and pains, few realize that when misused, acetaminophen can lead to acute liver failure and even death, often due to accidental overdose by an uninformed consumer. A new small ...

Recommended for you

Supercomputers link proteins to drug side effects

Oct 20, 2014

New medications created by pharmaceutical companies have helped millions of Americans alleviate pain and suffering from their medical conditions. However, the drug creation process often misses many side ...

No added benefit proven for umeclidinium/vilanterol in COPD

Oct 20, 2014

The drug combination umeclidinium/vilanterol (trade name Anoro) has been approved since May 2014 for adults with chronic obstructive pulmonary disease (COPD). In an early benefit assessment pursuant to the Act on the Reform ...

User comments